SMTL ID : 6r9h.2 (1 other biounit)

Crystal structure of the PDZ tandem of syntenin in complex with fragment C58

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

2 x ACT: ACETATE ION(Non-functional Binders)

ACT.1: 4 residues within 4Å: Chain A: H.101, V.102, G.103, F.104 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:V.102, A:G.103, A:F.104 Salt bridges: A:H.101 ACT.3: 4 residues within 4Å: Chain B: H.101, V.102, G.103, F.104 5 PLIP interactions: 5 interactions with chain B Hydrogen bonds: B:V.102, B:G.103, B:F.104, B:F.104 Salt bridges: B:H.101

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 4 residues within 4Å: Chain B: H.95, S.119, R.122, N.123 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:H.95, B:N.123 Salt bridges: B:H.95, B:R.122

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Leblanc, R. et al., Pharmacological inhibition of syntenin PDZ2 domain impairs breast cancer cell activities and exosome loadifing with syndecan and EpCAM cargo. J Extracell Vesicles (2020)

Release Date

2021-02-03

Peptides

Syntenin-1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

Syntenin-1

Related Entries With Identical Sequence